ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 730009 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 730009; 2) Community: the network communities that were significantly associated with the response to NSC 730009; 3) Molecule: the relationships between components within communities and NSC 730009; 4) MDR: the compounds that were significantly associated with the NSC 730009.

NSC Compound Enrichment Correlation
NSC 618939 Camptothecin Derivative 0.00162803849483079 0.70155127
NSC 719381 Null 0.00162803849483079 0.34637687
NSC 725774 6-[3-(Bis-hydroxyethylamino)-1-propyl]-5,6-dihydro-2,3-~ dimethoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride 0.00162803849483079 0.6864288
NSC 725775 6-[(3-Thiazolylamino)-1-propyl]-5,6-dihydro-2,3-dimethoxy-~ 8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride 0.00162803849483079 0.67461236
NSC 727354 6-[(4-FMOCamino)-1-butyl]-5,6-dihydro-2,3-dimethoxy-8,9-meth ylenedioxy-5,11-dioxo-11H-indeno[1,2-c-isoquinoline 0.00162803849483079 0.30462609
NSC 742149 Bisarylpurine 0.00162803849483079 -0.043557582
NSC 321521 SK&F 39162 0.00192786276806284 0.1507433
NSC 681684 2-Trifluoroethoxy-6-oxoestra-1,3,5(10)-trien-3,17.beta.-diol 0.00192786276806284 0.38888701
NSC 172614 9H-Purin-2-amine, 9-(2-deoxy-.beta.-D-erythro-pentofuranosyl)-6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]- 0.00243861794188205 0.32928124
NSC 19441 FDA 0283 0.00243861794188205 0.30869016
Total:90  Current:8    [First] [Prev] [Next] [Last]